CBX Daily 6/2/2025

Author

Abdul Karim
June 02, 2025

Today, Skechers avoids costly tariff wars with a $9B score, but let’s start with how Trump is shaking the pharma core…

Cultural Intelligence Download

Donald Trump’s Drug Order Could Cut Prices By Up To 80%

CBX Vibe

President Donald Trump is pushing for a dramatic shift in the U.S. pharmaceutical market with a new executive order aimed at slashing prescription drug prices by up to 80%. The order invokes a “Most Favored Nation” (MFN) pricing model, compelling drugmakers to match U.S. prices with the lowest rates charged in other comparable developed countries. As the U.S. prescription drug market prepares to hit $1.13 trillion in revenue by 2025, this bold policy could significantly reshape healthcare economics, industry profits, and access to life-saving treatments.

Skechers' $9 Billion Deal Signals A Retreat From Trade War Turmoil

CBX Vibe:

After nearly 30 years of being publicly traded, Skechers (SKX +0.07) is going steady. Skechers is set to transition to a private entity, offering its shareholders a 30% premium on their stock.  Great news for the shareholders; however, this move is worth reflecting on a little bit longer. This decision to go private comes in light of ongoing U.S.-China trade tensions that have disrupted supply chains and impacted profitability for many global retailers, including Skechers.

Are Tariffs Pricing Out Global Sneakerheads?

CBX Vibe:

If fashion is a language, sneakers are how many in the Black community speak. But a growing tariff war is making those expressions more expensive. With the U.S. imposing duties on imported footwear, especially from China where most sneakers are made. Consumers may soon feel the sting not just on their feet, but in their wallets to the tune of 30% tariff increase.

Tune-in Tuesdays!

It seems that Trump’s tariffs won’t bring back American manufacturing jobs and the reality sets in that protectionist policies just make headlines, not factories. Are voters still falling for the same broken promises dressed as patriotic plans?

A. “All Falls Down” by Kanye West ft. Syleena Johnson – Americans buy into the dream because it’s wrapped in pride, but under the surface, it’s all spin and sacrifice with no safety net when it breaks
B. “Déjà Vu” by Beyoncé – It’s the same script every election cycle and somehow, we’re expected to act surprised when the jobs never show up
C. “Money for Nothing” by Dire Straits – The promise of job resurgence is empty rhetoric because manufacturing doesn’t return, but the bill always does, and it’s the workers who foot it

What are your thoughts on this? Tune in next Tuesday to see which jam captures the prevailing sentiment!

A  |  B  |  C

Login or Subscribe to participate in polls.

Last week’s results are in and it seems people think Black women ‘Can’t Sit With Us’ at the big table

How Automation Powers Scalable Innovation

CBX Vibe:

Automation is not what it used to be a decade ago. Previously, it just meant offloading repetitive tasks to machines but in the ever evolving landscape of technology, it has become the cornerstone of achieving success in most businesses. Seeing the potential of automation, Realistic Computing CEO, Sequoia Ramsey, Simplicity IT CEO, Ameer Abdur-Razzaaq and Real Impact Technology CEO, Nyasha Tunduwani are at the forefront of ensuring organizations are embracing an 'automation-first' approach to future-proof their operations and scale efficiently for continued success.

There's A Confidence Deficit On The Economy & It's Personal

CBX Vibe:

Americans’ perceptions and emotions about the economy have tanked. U.S. consumer morale crashed to a score of 57.9 in March 2025 after falling 8% from earlier in the year, its lowest level since 2022. The University of Michigan’s Consumer Sentiment Index says more than that; there are doubts about the economy: It is a cultural barometer of escalating annoyance over inflation, political instability, and concerns about what lies ahead for American prosperity.

Vibes of the Week

Trump goes “Off Script” with a bold pharma move, as told by KeKe Palmer in our CBX Vibes!